MedSim acquires Eagle Simulation
Medical imaging simulation firm MedSim of Kfar Sava, Israel, has acquired Eagle Simulation of Binghamton, NY. The deal improves MedSim’s market position and expands its product line to include Eagle’s PatSim, a computer-controlled mannequin
Medical imaging simulation firm MedSim of Kfar Sava, Israel, has acquired Eagle Simulation of Binghamton, NY. The deal improves MedSims market position and expands its product line to include Eagles PatSim, a computer-controlled mannequin with cardiac, pulmonary, metabolic, and physiologic simulation functions. With the acquisition, MedSims worldwide installations will grow to more than 120 systems, and its annual consolidated sales will increase from $3.5 million to $8 million. Eagle will add 25 employees to MedSims roster, according to the company.
Newsletter
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
Key MRI Findings Predictive of Treatment Response for Unresectable Hepatocellular Carcinoma
July 14th 2025For patients with unresectable hepatocellular carcinoma, a pre-treatment MRI finding of LI-RADS tumor in vein was associated with over an 86 percent lower likelihood of responding to transcatheter arterial chemoembolization (TACE) and targeted immunotherapy.
